You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 4, April 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  EPIDEMIOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hepatitis Associated Antigen (HAA) in Pregnant Women and Their Newborn Infants

Peter Skinhøj, MD; Henrik Sardemann, MD; Jørgen Cohn, MD; Margareta Mikkelsen, MD; Henrik Olesen, MD

Am J Dis Child. 1972;123(4):380-381.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Neonatal hepatitis or giant-cell hepatitis is assumed to be a multi-etiologic syndrome.1 In some of the patients, however, the disease obviously is viral in origin and the significance of viral hepatitis in the mother during pregnancy has been discussed.2,3

Determination of hepatitis-associated antigen (HAA), a virus-like particle intimately related to long-incubation hepatitis (SH,MS-2),4,5 now seems to offer the opportunity to study the possible transmission of SH from pregnant women to their newborn.

The published case reports, however, have shown somewhat contradictory results.

Material and Methods

This investigation is based on a large-scale screening of all Danish pregnant women for HAA; the concluding findings will be published elsewhere.

Sera from 70,000 pregnant women were examined for HAA in an eight-month period; 82 carriers of the antigen were detected (1.2%). The carriers were followed-up until delivery and cord blood was obtained from the newborns. The children are currently being . . . [Full Text PDF of this Article]


Author Affiliations

Copenhagen

From the Department of Clinical Chemistry, Bispebjerg Hospital (Dr. Skinhøj); Milk Distribution Center, Children's Hospital at Fuglebakken (Dr. Sardemann); Department of Pediatrics, Rigshospitalet (Dr. Cohn); and the Kennedy Institute (Dr. Mikkelsen), Copenhagen.


Footnotes

Reprint requests to Department of Clinical Chemistry, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark (Dr. Skinhøj).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.